Skip to main content
. 2022 Dec 13;14(12):2790. doi: 10.3390/pharmaceutics14122790

Figure 8.

Figure 8

(a) Preparation, (b,c) characterization, and (df) drug delivery of CD-MOFs and KET-CD-MOFs. Reproduced with permission from Ref. [80], copyright (2019) the American Chemical Society.